Chardan Capital Markets Downgrades Opexa Therapeutics (OPXA) to Neutral

October 28, 2016 11:25 AM EDT
Get Alerts OPXA Hot Sheet
Price: $0.92 --0%

Rating Summary:
    2 Buy, 2 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 7 | Down: 8 | New: 1
Trade OPXA Now!
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

Chardan Capital Markets downgraded Opexa Therapeutics (NASDAQ: OPXA) from Buy to Neutral with a price target of $1.00.

For an analyst ratings summary and ratings history on Opexa Therapeutics click here. For more ratings news on Opexa Therapeutics click here.

Shares of Opexa Therapeutics closed at $3.40 yesterday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities

Chardan Capital Markets

Add Your Comment